Human monocytes produce interferon-gamma upon stimulation with LPS

Cytokine

Volumn 67, Issue 1, 2014, Pages 7-12

  Kraaij, Marina D ^a   Vereyken, Elly J F ^a   Leenen, Pieter J M ^a   van den Bosch, Thierry P P ^a   Rezaee, Farhad ^b   Betjes, Michiel G H ^a   Baan, Carla C ^a   Rowshani, Ajda T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

IFN ; LPS; Macrophage; Monocytes; Transplantation

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; BASILIXIMAB; CD14 ANTIGEN; CD68 ANTIGEN, HUMAN; CORTICOSTEROID; DIFFERENTIATION ANTIGEN; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; TACROLIMUS;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; KIDNEY GRAFT; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CELL CULTURE; GENETICS; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM;

ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELLS, CULTURED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; LIPOPOLYSACCHARIDES; MONOCYTES; MYCOPHENOLIC ACID; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894582398     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.02.001     Document Type: Article

References (43)

1. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukocyte Biol 2004, 75:163-189.
2. Seliger B., Ruiz-Cabello F., Garrido F. IFN inducibility of major histocompatibility antigens in tumors. Adv Cancer Res 2008, 101:249-276.
3. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu Rev Immunol 1997, 15:749-795.
4. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999, 163:4647-4650.
5. Finkelman F.D., Katona I.M., Mosmann T.R., Coffman R.L. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988, 140:1022-1027.
6. Frucht D.M., Fukao T., Bogdan C., Schindler H., O'Shea J.J., Koyasu S. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol 2001, 22:556-560.
7. Gutcher I., Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 2007, 117:1119-1127.
8. Martins T.B., Rose J.W., Jaskowski T.D., Wilson A.R., Husebye D., Seraj H.S., et al. Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. Am J Clin Pathol 2011, 136:696-704.
9. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 1:893-895.
10. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 2001, 194:669-676.
11. Cooper S.M., Sriram S., Ranges G.E. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol 1988, 141:1958-1962.
12. Mauritz N.J., Holmdahl R., Jonsson R., Van der Meide P.H., Scheynius A., Klareskog L. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthr Rheum 1988, 31:1297-1304.
13. Xie L., Ichimaru N., Morita M., Chen J., Zhu P., Wang J., et al. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl 2012, 18:444-454.
14. Ring G.H., Saleem S., Dai Z., Hassan A.T., Konieczny B.T., Baddoura F.K., et al. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. Transplantation 1999, 67:1362-1365.
15. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 1988, 140:1506-1510.
16. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 1996, 14:301-331.
17. Cartwright N.H., Demaine A.G., Hurlock N.J., McGonigle R.J., Rowe P.A., Shaw J.F., et al. Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transpl Immunol 2000, 8:109-114.
18. Sadeghi M., Daniel V., Weimer R., Wiesel M., Hergesell O., Opelz G. Pre-transplant Th1 and post-transplant Th2 cytokine patterns are associated with early acute rejection in renal transplant recipients. Clin Transpl 2003, 17:151-157.
19. Suresh V., Carey B.S., Shaw S., Tse W.Y., Cartwright N., Akoh J., et al. A retrospective study of the prognostic impact of cytokine secretion in mixed lymphocyte culture on long-term graft function following allogeneic renal transplantation. Transpl Int 2005, 18:1067-1071.
20. Buob D., Hazan M., Homs S., Matignon M., Mansour H., Audard V., et al. Intrarenal IFN-gamma mRNA expression differentiates clinical and subclinical glomerulitis in renal transplant recipients. Transplantation 2011, 92:170-175.
21. Wieckiewicz J., Goto R., Wood K.J. T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol 2010, 22:662-668.
22. Flechner S.M., Kurian S.M., Head S.R., Sharp S.M., Whisenant T.C., Zhang J., et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transpl 2004, 4:1475-1489.
23. Hancock W.W., Thomson N.M., Atkins R.C. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 1983, 35:458-463.
24. Pietra B.A., Wiseman A., Bolwerk A., Rizeq M., Gill R.G. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000, 106:1003-1010.
25. Uehara S., Chase C.M., Cornell L.D., Madsen J.C., Russell P.S., Colvin R.B. Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transpl 2007, 7:57-65.
26. Wood K.J., Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012, 93:1-10.
27. Magil A.B. Monocytes/macrophages in renal allograft rejection. Transpl Rev (Orlando) 2009, 23:199-208.
28. Rowshani A.T., Vereyken E.J. The role of macrophage lineage cells in kidney graft rejection and survival. Transplantation 2012, 94:309-318.
29. Halloran P.F., Reeve J.P., Pereira A.B., Hidalgo L.G., Famulski K.S. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies. Kidney Int 2013.
30. Girlanda R., Kleiner D.E., Duan Z., Ford E.A., Wright E.C., Mannon R.B., et al. Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transpl 2008, 8:600-607.
31. Tinckam K.J., Djurdjev O., Magil A.B. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005, 68:1866-1874.
32. Kirk A.D., Hale D.A., Mannon R.B., Kleiner D.E., Hoffmann S.C., Kampen R.L., et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003, 76:120-129.
33. Kutukculer N., Shenton B.K., Clark K., Rigg K.M., Forsythe J.L., Kirby J.A., et al. Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1. Transpl Int 1995, 8:45-50.
34. Hidalgo L.G., Halloran P.F. Role of IFN-gamma in allograft rejection. Crit Rev Immunol 2002, 22:317-349.
35. Schleicher U., Hesse A., Bogdan C. Minute numbers of contaminant CD8+ T cells or CD11b+ CD11c+ NK cells are the source of IFN-gamma in IL-12/IL-18-stimulated mouse macrophage populations. Blood 2005, 105:1319-1328.
36. Choudhry N., Petry F., van Rooijen N., McDonald V. A protective role for interleukin 18 in interferon gamma-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells. J Infect Dis 2012, 206:117-124.
37. Fenton M.J., Vermeulen M.W., Kim S., Burdick M., Strieter R.M., Kornfeld H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immunol 1997, 65:5149-5156.
38. Nagayama H., Sato K., Kawasaki H., Enomoto M., Morimoto C., Tadokoro K., et al. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J Immunol 2000, 165:59-66.
39. Pietila T.E., Veckman V., Kyllonen P., Lahteenmaki K., Korhonen T.K., Julkunen I. Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells. J Leukocyte Biol 2005, 78:909-920.
40. Sarhan D., D'Arcy P., Wennerberg E., Liden M., Hu J., Winqvist O., et al. Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-gamma. Eur J Immunol 2013, 43:249-257.
41. Vereyken E.J., Kraaij M.D., Baan C.C., Rezaee F., Weimar W., Wood K.J., et al. A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation. PLoS One 2013, 8:e70152.
42. Chusid L.A., Pereira-Argenziano L., Miskolci V., Vancurova I., Davidson D. Transcriptional control of cytokine release from monocytes of the newborn: effects of endogenous and exogenous interleukin-10 versus dexamethasone. Neonatology 2010, 97:108-116.
43. Li L.B., Leung D.Y., Hall C.F., Goleva E. Divergent expression and function of glucocorticoid receptor beta in human monocytes and T cells. J Leukocyte Biol 2006, 79:818-827.